P3 Health Partners (PIII) Q3 2024 earnings summary

Executive summary

• Revenue grew 26% year-over-year to $362.1 million in Q3 2024, driven by a 22% increase in membership and expansion into new counties.

• The company is navigating a challenging Medicare Advantage environment with elevated medical utilization, retroactive adjustments, and lower risk adjustments impacting results.

• Over $130 million in improvement initiatives are underway, focusing on contracts, operational discipline, efficiency, and data analytics, with management targeting profitability and cash flow improvement in 2025.

• Net loss attributable to controlling interest was $46.5 million for Q3 2024, with a gross loss of $39.8 million, reflecting higher medical expenses and premium deficiency reserves.

• The company operates under a capitated, at-risk model, serving 3,100 primary care physicians across 27 markets in five states.

Financial highlights

• Capitated revenue reached $357.7 million; total revenue was $362.1 million for Q3 2024, up 25–26% year-over-year.

• Medical margin was $0.5 million ($1 PMPM), down from $36.2 million; adjusted EBITDA loss was $71 million ($184 PMPM), compared to $22.3 million in Q3 2023.

• Gross loss for Q3 2024 was $39.8 million, compared to gross profit of $9.1 million in Q3 2023.

• Net loss widened to $102.9 million from $37.3 million; net loss per share (basic) was $0.29.

• Cash and restricted cash at quarter-end totaled $68.1 million, including a $15 million deposit for the Florida asset sale.

Outlook and guidance

• No formal outlook provided; 2024 guidance was withdrawn due to lower risk adjustment, elevated medical costs, and retroactive adjustments.

• Management expects improvement in EBITDA and cash flow in 2025 as initiatives phase in, with benefit design changes and Medicare Advantage repricing anticipated to reduce utilization.

• Some revenue decline expected in 2025 due to network rationalization, with approximately 20,000 members impacted.

• Completion of the sale of Florida operations is expected in Q4 2024, with a $15 million deposit already received.